Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationTransplantation ConditioningAnemia, AplasticGraft SurvivalKidney TransplantationTissue DonorsLeukemiaTransplantation ChimeraGenetic TherapyLiver TransplantationBusulfanHistocompatibility TestingBone Marrow PurgingHematopoietic Stem CellsHistocompatibilityGraft RejectionTransplantation, IsogeneicCyclophosphamideImmunosuppressive AgentsBone Marrow DiseasesRecurrenceMice, Inbred C57BLCombined Modality TherapyHematopoiesisTreatment OutcomeHeart TransplantationTime FactorsRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteTransplantation ImmunologyBone Marrow ExaminationHematologic NeoplasmsImmunosuppressionLung TransplantationGenetic VectorsPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseRemission InductionStem Cell TransplantationBone RemodelingSevere Combined ImmunodeficiencyBone Marrow NeoplasmsGraft vs Host ReactionLeukemia, MyeloidAcute DiseaseLymphocyte DepletionRetrospective StudiesCyclosporineLeukocyte TransfusionLymphoma, Non-HodgkinT-LymphocytesSurvival AnalysisHLA AntigensChimeraColony-Forming Units AssayMyelodysplastic SyndromesCytomegalovirus InfectionsHematologic DiseasesActuarial AnalysisLymphocyte TransfusionTransplantationFollow-Up StudiesBone DensitySurvival RateGene Transfer TechniquesMice, Inbred BALB CNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsTransplantsCarmustineCell DifferentiationGraft vs Tumor EffectOrgan TransplantationGraft vs Leukemia EffectPancytopeniaLeukocyte CountFlow CytometrySpleenCytarabineGranulocyte Colony-Stimulating FactorCells, CulturedMelphalanDisease-Free SurvivalBone ResorptionPostoperative ComplicationsCell TransplantationLiving DonorsAntigens, CD34EtoposideFatal OutcomeLymphoma